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Quassinoids, isolated from the Simaroubaceous plants, demonstrates various biological activities, 
such as antitumor, anti-inflammatory, antimalarial. amoebicidal, antifeedant, insecticidal, and 
herbicidal e在ects.As a result, theるitterprinciples have been extensively investigated from a 
structural viewpoint, their versatile biological activity, and interesting structure-activity 
relationships. 
The discovery of the potent antineoplastic activity of bruceantin, a quassinoid from Brucea 
antidysenterica, which was in phase Icrinical trial as an anticancer drug by the National Cancer 
Institute of USA, has generated much synthetic and biological interest in this class of natural 
詐oductsfrom the Simaroubaceae. Later detailed investigation on the same species led to the 
isolation of many antile世cemicquassinoids. 
The fruits of Bruceajavanica (L.) Merr. are well known as“Ya Tan-Tzu" in Chinese folklore as 
herbal remedies for human cancer, malaria, as well as for amoebiasis. The quassinoid bruεeoside C 
isolated from this plant demonstrated potent cytotoxicity against human epidermoid carcinoma of 
the nasopharynx and CNS carcinoma, as well as murine lymphocytic leukemia. The novel 
司uassinoids訂ruceosidesD, E, and F from the same species showed selective cytotoxicity in 
leukemia, non-small cel lung cancer, prostate cancer, and己reastcancer cel lines. 
The inhibitory activities of forty-five natural quassinoids on 12-0-tetradecanoyl phorるol-13-
acetate (TPA)-induced Epstein-Barr virus early antigen (EBV-EA) activation and their potential as 
anti-tumor-promoting agents haveるeenreported, of which fifteen quassinoids were isolated from 
Brucea javanica. 
As a result of our profound interest in the bioactive constituents of Ya-Tan-Tzu as well as the 
structure-activity relationship corelation, we carried out a detailed investigation on the 
components of the 1-butanol extract. Recently, we isolated a new quassinoid, desmethyl-brusatol, 
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and two new quassinoid glucosides, bruceoside G and bruceoside H. Their structures were 
elucidated by spectral evidence such as UV, IR, NMIミぐH，日C,DEPT, 1H-1H, and z℃－1H COSY), and MS 
(HRSIMS) and chemical transformation to or from the known compopunds. During the process of 
isolation of new quassinoids, known quassinoids were also isolated. 
Since in structure-activity relationship studies of antitumor and anti-inflammatory立uassinoids,
we found that the lipophilicity of the ester side chain is very important for the activity. However, 
むruceantinhas not yet progressed to drug development. Enzymatic oxidation of the side chain 
might cause deactivation of the quassinoid and limit its efficacy. 
Accordingly, substituting the side chain with a moiety more stable to oxidation might prove 
beneficial. Introducing fluorine into the quassinoid side chain might increase both lipophilicity and 
bond strength. The modified quassinoid then could be transported easily into the cel，るutmight not 
be decomposed by enzymatic oxidation. So, quassinoid derivatives with fluorine were decided to 
synthesize. 
Isobr・uceinB, a major quassinoid was isolated from Brucea antidysenterica. The acetyl group of 
isobrucein B was removed by alkaline hydrolysis to desacetyl-isobrucein B. Then, five quassinoid 
derivatives were prepared by esterification of desacetyl-isobrucein B with the following acid 
chlorides: isovaleryl chloride, 3,3-dimethylacryloyl chloride, 4ム4-trifluoromethylbutanoylchloride, 
3-fluorobenzoyl chloride, and 3-trifluoromethylむenzoylchloride. The structures of the 
semisynthetic quassinoids were con五rmedby spectral evidence. 
We are very intersted in determining various biological activities of the quassinoids, especially 
antitumor, anti-tumor-promoting, and anti-HIV e宜ects.まecently,seventy-two quassinoids which 
were isolated from the four plants of Simaroubaceae or derived from natural quassinoids were 
assayed as inhibitors against Epstein-Barr virus early antigen (EBV-EA) activation and over al 
structure-activity relationships were discussed: (a) a methylenoxy bridge, an ester side chain, and 
fluorination of the side chain (especially aliphatic one) enhance the activity, but (b) a sugar moiety 
reduces the activity. 
The three new quassinoids and related five other compounds were more active than the reference 
compounds, curcumin, [3-carotene, and glycyrrhizin. Desmethyl-brusatol and bruceoside G (which 
is desmethyl七ruceantinosideA) were less active than brusatol and己主uceantinosideA, respectively. 
Similarly, bruceosideヨ（thebutyl ester ofbruceoside D) was more active than bruceoside D. 
All the ester derivatives showed higher anti-tumor-promoting activity than that of the potent 
stirting material, desacetyl-isobrucein B. The derivative containing宣uorinatedaliphatic ester side 
chain showed the highest potency. 
Isobrucein B was assayedおrtherfor in vivo inhibitory e宣ectagainst mouse skin tumor promotion 
and the result was very promising. 
TAACF (the tuberculosis antimicrobial acquisition and coordinating facility) has set up a new 
drug screening program to discover novel agents for the treatment of tuberculosis. We were 
interested in this program and sent fifty-six quassinoids isolated in our i泊oratoryfrom the 
Simaroubaceous plants, Brucea javanica, Brucea antidysenterica，日・crasmaailan thoides, and 
Ailanthus altissima for screening as anti-tuberculosis agent. As a result, eighteen quassinoids 
showed anti-tuberculosis activity. Although the activities were very low, the resulting data 
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provided a picture of structure-activity relationships which may provide clues for the development 
of more active compounds, and structural diversity is very important for the drug discovery e百ort.
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